RECRUITING

Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this project is to evaluate the performance of Picterus Jaundice Pro in an American population, including preterm and term newborns and pre- and post- phototherapy.

Official Title

Intermountain Inpatient Bilirubin Decision Accuracy Study Using Smartphone-based Measurements by Picterus Jaundice Pro

Quick Facts

Study Start:2024-02-12
Study Completion:2024-05
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06329843

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:12 Hours to 192 Hours
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * the patient is free of skin rash, bruising, or other medical conditions that can interfere with transcutaneous measurement
  2. * (preterm) \< = 35 weeks gestational age
  3. * (term) \> 35 weeks gestational age
  4. * the patient has not been excluded by PI discretion.
  1. * Neonates will be excluded from participation if all four inclusion criteria listed above are not met.

Contacts and Locations

Study Contact

Timothy M Bahr, MS MD
CONTACT
801-602-6523
Tim.Bahr@imail.org
Kimberlee W Lewis, MS RN
CONTACT
801-507-7675
kimberlee.weaverlewis@imail.org

Principal Investigator

Timothy M Bahr, MS MD
PRINCIPAL_INVESTIGATOR
Intermountain Health Care, Inc.

Study Locations (Sites)

Intermountain Health
Salt Lake City, Utah, 84132
United States

Collaborators and Investigators

Sponsor: Picterus AS

  • Timothy M Bahr, MS MD, PRINCIPAL_INVESTIGATOR, Intermountain Health Care, Inc.

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-02-12
Study Completion Date2024-05

Study Record Updates

Study Start Date2024-02-12
Study Completion Date2024-05

Terms related to this study

Keywords Provided by Researchers

  • jaundice
  • neonate
  • phototherapy

Additional Relevant MeSH Terms

  • Neonatal Jaundice